These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

410 related articles for article (PubMed ID: 32627299)

  • 1. Diabetes, obesity and COVID-19: A complex interplay.
    Vas P; Hopkins D; Feher M; Rubino F; B Whyte M
    Diabetes Obes Metab; 2020 Oct; 22(10):1892-1896. PubMed ID: 32627299
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Centrality of Obesity in the Course of Severe COVID-19.
    Liu D; Zhang T; Wang Y; Xia L
    Front Endocrinol (Lausanne); 2021; 12():620566. PubMed ID: 33776917
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Obesity and diabetes as high-risk factors for severe coronavirus disease 2019 (Covid-19).
    Zhou Y; Chi J; Lv W; Wang Y
    Diabetes Metab Res Rev; 2021 Feb; 37(2):e3377. PubMed ID: 32588943
    [TBL] [Abstract][Full Text] [Related]  

  • 4. COVID-19, ketoacidosis and new-onset diabetes: Are there possible cause and effect relationships among them?
    Gentile S; Strollo F; Mambro A; Ceriello A
    Diabetes Obes Metab; 2020 Dec; 22(12):2507-2508. PubMed ID: 32790021
    [No Abstract]   [Full Text] [Related]  

  • 5. Prevalence of co-morbidities and their association with mortality in patients with COVID-19: A systematic review and meta-analysis.
    Singh AK; Gillies CL; Singh R; Singh A; Chudasama Y; Coles B; Seidu S; Zaccardi F; Davies MJ; Khunti K
    Diabetes Obes Metab; 2020 Oct; 22(10):1915-1924. PubMed ID: 32573903
    [TBL] [Abstract][Full Text] [Related]  

  • 6. COVID-19 and Diabetes: Understanding the Interrelationship and Risks for a Severe Course.
    Landstra CP; de Koning EJP
    Front Endocrinol (Lausanne); 2021; 12():649525. PubMed ID: 34220706
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incidence of diabetes mellitus and associated risk factors in the adult population of the Basque country, Spain.
    Urrutia I; Martín-Nieto A; Martínez R; Casanovas-Marsal JO; Aguayo A; Del Olmo J; Arana E; Fernandez-Rubio E; Castaño L; Gaztambide S;
    Sci Rep; 2021 Feb; 11(1):3016. PubMed ID: 33542348
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diabetes and covid-19: more than the sum of two morbidities.
    Pititto BA; Ferreira SRG
    Rev Saude Publica; 2020; 54():54. PubMed ID: 32491053
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diabetes and COVID-19; A Bidirectional Interplay.
    Kazakou P; Lambadiari V; Ikonomidis I; Kountouri A; Panagopoulos G; Athanasopoulos S; Korompoki E; Kalomenidis I; Dimopoulos MA; Mitrakou A
    Front Endocrinol (Lausanne); 2022; 13():780663. PubMed ID: 35250853
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tackling obesity during the COVID-19 pandemic.
    Akirov A; Cahn A; Del Prato S; Home P; Van Gaal L; Chan J; Ning G; Raz I
    Diabetes Metab Res Rev; 2021 Mar; 37(3):e3393. PubMed ID: 32797666
    [No Abstract]   [Full Text] [Related]  

  • 11. Influence of diabetes mellitus on the severity and fatality of SARS-CoV-2 (COVID-19) infection.
    Wu J; Zhang J; Sun X; Wang L; Xu Y; Zhang Y; Liu X; Dong C
    Diabetes Obes Metab; 2020 Oct; 22(10):1907-1914. PubMed ID: 32496012
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diabetes, obesity, metabolism, and SARS-CoV-2 infection: the end of the beginning.
    Drucker DJ
    Cell Metab; 2021 Mar; 33(3):479-498. PubMed ID: 33529600
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence and impact of diabetes and cardiovascular disease on clinical outcome among patients with COVID-19 in Bangladesh.
    Sharif N; Ahmed SN; Opu RR; Tani MR; Dewan D; Daullah MU; Shanto RI; Parvez AK; Talukder AA; Dey SK
    Diabetes Metab Syndr; 2021; 15(3):1009-1016. PubMed ID: 33993046
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of obesity on COVID-19 patients.
    Yu W; Rohli KE; Yang S; Jia P
    J Diabetes Complications; 2021 Mar; 35(3):107817. PubMed ID: 33358523
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk factors for Covid-19 severity and fatality: a structured literature review.
    Wolff D; Nee S; Hickey NS; Marschollek M
    Infection; 2021 Feb; 49(1):15-28. PubMed ID: 32860214
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship between COVID-19 and obesity.
    Ekiz T; Pazarlı AC
    Diabetes Metab Syndr; 2020; 14(5):761-763. PubMed ID: 32505980
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is diabetes mellitus a risk factor for COronaVIrus Disease 19 (COVID-19)?
    Pugliese G; Vitale M; Resi V; Orsi E
    Acta Diabetol; 2020 Nov; 57(11):1275-1285. PubMed ID: 32865671
    [TBL] [Abstract][Full Text] [Related]  

  • 18. One year into the clash of pandemics of diabetes and COVID-19: Lessons learnt and future perspectives.
    Lui DTW; Lee CH; Tan KCB
    J Diabetes Investig; 2022 Jan; 13(1):19-21. PubMed ID: 34375500
    [TBL] [Abstract][Full Text] [Related]  

  • 19. COVID-19 severity in obese patients: Potential mechanisms and molecular targets for clinical intervention.
    Sharma JR; Yadav UCS
    Obes Res Clin Pract; 2021; 15(2):163-171. PubMed ID: 33509701
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Possible consequences of Covid-19 on the nervous system.
    Sramka M; Slavik J; Masan J; Ruzicky E
    Neuro Endocrinol Lett; 2020 Oct; 41(4):166-172. PubMed ID: 33307651
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.